Joshua is an engineer with over 20 years of experience as a CEO. He is a multi-patent inventor, including anti-viral applications of Maxwell's platform technology. His background includes leading engineering teams, as well as military and commercial intelligence. He is a pioneer in the field of plasma proteomics and biomimetics. He has wide ranging interests in physics, nanobiology, and information theory and his knowledge of leadership principles and the relationship of human proteins to health outcomes are the foundation and driving force of the company. Joshua is a graduate of the USAF Academy, with a B.S. in Management. He also holds a Masters of Business Administration from the University of Massachusetts.